Barrington Strategic Wealth Management Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$1.73M Buy
22,505
+44
+0.2% +$3.32K 0.87% 32
2017
Q2
$1.68M Sell
22,461
-756
-3% -$53.6K 0.85% 34
2017
Q1
$1.54M Sell
23,217
-184
-0.8% -$12.3K 0.8% 33
2016
Q4
$1.53M Sell
23,401
-904
-4% -$58.6K 0.82% 34
2016
Q3
$1.72M Sell
24,305
-824
-3% -$60K 0.97% 29
2016
Q2
$1.86M Sell
25,129
-318
-1% -$22K 1.06% 23
2016
Q1
$1.65M Sell
25,447
-977
-4% -$66.5K 0.96% 28
2015
Q4
$2.04M Sell
26,424
-306
-1% -$24.3K 1.19% 23
2015
Q3
$2.2M Sell
26,730
-250
-0.9% -$22.3K 1.4% 21
2015
Q2
$2.38M Buy
26,980
+50
+0.2% +$4.59K 1.43% 21
2015
Q1
$2.38M Buy
26,930
+214
+0.8% +$19K 1.46% 18
2014
Q4
$2.22M Buy
26,716
+499
+2% +$41.4K 1.42% 20
2014
Q3
$2.21M Sell
26,217
-1,150
-4% -$93K 1.43% 16
2014
Q2
$2.22M Sell
27,367
-469
-2% -$36.9K 1.41% 20
2014
Q1
$2.12M Buy
27,836
+219
+0.8% +$16K 1.38% 19
2013
Q4
$1.99M Buy
27,617
+1,600
+6% +$111K 1.33% 20
2013
Q3
$1.79M Buy
26,017
+820
+3% +$54.3K 1.58% 18
2013
Q2
$1.6M Buy
+25,197
New +$1.64M 1.31% 22

Other funds holding NVS

Barrington Strategic Wealth Management Group's NVS Position: Q3 2017 in Review

Barrington Strategic Wealth Management Group increased its Novartis (NVS) stake by 0.2% in Q3 2017, buying an estimated $3.32K and bringing the position to 22,505 shares worth $1.73M. The position accounts for 0.87% of the portfolio, ranked #32.

Barrington Strategic Wealth Management Group first reported a position in NVS in Q2 2013 and has held it in 18 quarters since. The position peaked at $2.38M in Q1 2015. 937 funds tracked by Wall St. Rank hold NVS as of Q3 2017.

  • Barrington Strategic Wealth Management Group held 22,505 shares of Novartis worth $1.73M as of Q3 2017.
  • Barrington Strategic Wealth Management Group bought 44 Novartis shares in Q3 2017, an estimated $3.32K.
  • Novartis made up 0.87% of Barrington Strategic Wealth Management Group's portfolio in Q3 2017, its #32 holding.
  • Barrington Strategic Wealth Management Group first reported a position in Novartis in Q2 2013 and has held it in 18 quarters since.
  • Barrington Strategic Wealth Management Group's Novartis position peaked at $2.38M in Q1 2015.
  • 937 funds tracked by Wall St. Rank held Novartis as of Q3 2017.

Based on Barrington Strategic Wealth Management Group's 13F filing for Q3 2017, filed 31 Oct 2017.